Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Deep Learning-Assisted Detection and Classification of Thymoma Tumors in CT Scans
0
Zitationen
5
Autoren
2025
Jahr
Abstract
<b>Background/Objectives:</b> Thymoma is a rare epithelial neoplasm originating from the thymus gland, and its accurate detection and classification using computed tomography (CT) images remain diagnostically challenging due to subtle morphological similarities with other mediastinal pathologies. This study presents a deep learning (DL)-based model designed to improve diagnostic accuracy for both thymoma detection and subtype classification (benign vs. malignant). <b>Methods:</b> The proposed approach integrates a pre-trained VGG16 network for efficient feature extraction-capitalizing on its capacity to capture hierarchical spatial features-and an MLP-Mixer-based feature enhancement module, which effectively models both local and global feature dependencies without relying on conventional convolutional mechanisms. Additionally, customized preprocessing and post-processing methods are employed to enhance image quality and suppress redundant data. The model's performance was evaluated on two classification tasks: distinguishing thymoma from healthy cases and discriminating between benign and malignant thymoma. Comparative analysis was conducted against state-of-the-art DL models including ResNet50, ResNet34, SEResNeXt50, InceptionResNetV2, MobileNetV2, VGG16, InceptionV3, and DenseNet121 using metrics such as F1 score, accuracy, recall, and precision. <b>Results:</b> The model proposed in this study obtained its best performance in thymoma vs. healthy classification, with an accuracy of 97.15% and F1 score of 80.99%. In the benign vs. malignant task, it attained an accuracy of 79.20% and an F1 score of 78.51%, outperforming all baseline methods. <b>Conclusions:</b> The integration of VGG16's robust spatial feature extraction and the MLP-Mixer's effective feature mixing demonstrates superior and balanced performance, highlighting the model's potential for clinical decision support in thymoma diagnosis.
Ähnliche Arbeiten
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 · 3.200 Zit.
Myasthenia Gravis
1997 · 2.405 Zit.
Follow-up study of thymomas with special reference to their clinical stages
1981 · 1.712 Zit.
Localized mediastinal lymph-node hyperplasia resembling thymoma
1956 · 1.619 Zit.
Myasthenia gravis
2000 · 1.590 Zit.